Thyrotoxicosis: an under-recognised aetiology

Systemic lupus erythematosus and thyrotoxicosis: a hitherto little recognised association.

Six patients are reported in whom systemic lupus erythematosus (SLE) and thyrotoxicosis coexisted. All had four or more American Rheumatism Association criteria (1982) for the diagnosis of SLE and had clinical manifestations and function test results characteristic of hyperthyroidism (except for one who had been thyroidectomised previously). In three patients the diagnosis of hyperthyroidism pr...

Non-typeable Haemophilus influenzae, an under-recognised pathogen

Analogues of erectile dysfunction drugs: an under-recognised threat.

OBJECTIVES To investigate the problem of drug analogue adulteration in male erectile dysfunction health products. DESIGN Survey of over-the-counter male erectile dysfunction health products available in convenience stores and pharmacies in Hong Kong. SETTING Tertiary referral centre for clinical toxicology analysis in Hong Kong. MAIN OUTCOME MEASURES The pattern and extent of adulteration...

Non-typeable Haemophilus influenzae, an under-recognised pathogen.

Non-typeable Haemophilus influenzae (NTHi) is a major cause of mucosal infections such as otitis media, sinusitis, conjunctivitis, and exacerbations of chronic obstructive pulmonary disease. In some regions, a strong causal relation links this pathogen with infections of the lower respiratory tract. In the past 20 years, a steady but constant increase has occurred in invasive NTHi worldwide, wi...

Orlistat, an under-recognised cause of progressive renal impairment.

Obesity is an emerging risk factor for chronic kidney disease (CKD) in the developed world. Orlistat, an intestinal lipase inhibitor, used in the treatment of obesity is available as an over-the-counter medication across the European union and in many countries worldwide. It is associated with acute kidney injury (AKI). We present three adults, followed up from 1 to 6 years, who developed de no...